Criminal Charges and Michigan Pharmacists: Protecting Your Pharmacy License and Career

A Michigan pharmacist facing a criminal charge occupies a uniquely vulnerable professional position. Unlike most licensed healthcare professionals whose criminal exposure involves occasional access to controlled substances, a pharmacist's core professional function is the dispensing and management of those substances. Any criminal charge that touches controlled substances, billing integrity, or professional conduct simultaneously implicates the pharmacy license, DEA registration, and federal program participation in ways that can move faster, and with less procedural protection, than almost any other licensed profession. Early criminal defense strategy that accounts for all three of those tracks from the first day is not a refinement for pharmacists. It is the only approach that preserves any meaningful chance of protecting the career.

This page addresses criminal charges and their specific implications for licensed pharmacists in Michigan. The consequence framework that governs all licensed healthcare professionals in Michigan, including how Michigan's Public Health Code classifies the three categories of consequence that flow from any criminal conviction, how reporting obligations work, and how criminal defense strategy must be coordinated with healthcare licensing counsel from the investigation stage, is developed in the firm's analysis of criminal charges and licensed healthcare professionals in Michigan.

Why Pharmacists Face the Most Rapidly Moving Consequence Profile of Any Licensed Healthcare Professional

Pharmacists are in a structurally distinct position when criminal charges arise. Physicians and nurses face controlled substance consequences when criminal conduct involves their incidental access to those substances. For pharmacists, controlled substance management is not incidental. It is the professional function itself.

A pharmacist who faces any charge touching controlled substances, whether diversion, fraudulent dispensing, billing irregularities, or record falsification, faces a consequence profile in which the licensing authority, the DEA, and federal program administrators may each act simultaneously and on accelerated timelines because the alleged conduct lies at the center of what the license authorizes.

Patrick Barone's published analysis of criminal charges and their licensing consequences for Michigan healthcare professionals, developed across more than three decades of representing licensed professionals in this state, identifies this convergence of simultaneous tracks as the defining structural risk of pharmacist criminal matters.

The DEA's regulatory relationship with pharmacies is more direct and more routinely exercised than its relationship with most other licensed prescribers or dispensers. DEA inspections of pharmacies are a regular feature of regulatory enforcement, not an exceptional response to suspected wrongdoing.

When a criminal investigation of a pharmacist begins, the DEA's existing familiarity with the pharmacy's dispensing records, inventory reconciliation, and controlled substance logs means the evidentiary foundation for a licensing and registration action may already exist before any criminal charge is filed.

For pharmacists employed by large retail pharmacy chains, hospital systems, or long-term care pharmacy operations, the employer's own compliance infrastructure adds another layer. Internal pharmacy audits, PBM reconciliation reviews, and inventory discrepancy flags frequently generate the initial signal that leads to a DEA referral or a criminal investigation. By the time law enforcement is involved, the employer may have already assembled a record of dispensing irregularities that the criminal prosecution will rely on heavily.

How Michigan Pharmacists Are Licensed and What Authority Governs Disciplinary Action

Michigan pharmacists are licensed by LARA, acting through the Bureau of Professional Licensing and the Michigan Board of Pharmacy, under the authority of Article 15 of the Michigan Public Health Code. The Board of Pharmacy oversees the licensure of pharmacists, pharmacy interns, and pharmacy technicians, and exercises disciplinary authority over all of them under MCL § 333.16221.

The Board's disciplinary framework applies a fitness and public safety standard, not a criminal court's proportionality framework. A conviction that a criminal court treats as a misdemeanor may be evaluated by the Board of Pharmacy as conduct that goes to the core of professional fitness, because for a pharmacist, the integrity of controlled substance management and billing practices is not incidental to the professional role. It is the professional role.

The Board has historically applied this principle strictly, and a conviction of any kind involving controlled substances, billing integrity, or professional honesty will trigger a disciplinary review regardless of how the criminal matter was resolved.

Under MCL § 333.16233(5), LARA has authority to impose a summary suspension before any formal hearing when an immediate threat to public health, safety, or welfare exists. For pharmacists facing controlled substance charges, summary suspension can remove the pharmacist from practice and effectively close or cripple a pharmacy operation before any adjudication.

That possibility makes early intervention, including early engagement of healthcare licensing counsel, a matter of genuine urgency rather than a precautionary preference.

Once a criminal conviction is reported to LARA and a formal administrative complaint is issued, the licensing proceeding begins. That proceeding may include the compliance conference mechanism authorized under MCL § 333.16231(5), an informal proceeding before the disciplinary subcommittee at which the pharmacist, represented by healthcare licensing counsel, can present context, demonstrate remediation steps, and potentially resolve the licensing matter without formal public discipline. The compliance conference is the licensing specialist's proceeding.

What determines the pharmacist's position at that conference is entirely a product of decisions made in the criminal case long before the licensing proceeding begins. That is why the firm engages healthcare licensing counsel from the earliest stage of the criminal matter, coordinating strategy across both tracks simultaneously so that the criminal defense is built with the administrative outcome in mind from day one.

How Does a Criminal Conviction Affect a Pharmacist's DEA Registration?

A pharmacist's DEA registration is the authorization that makes the core professional function legally possible. A pharmacist without a DEA registration cannot dispense Schedule II through V controlled substances, which means a pharmacist without DEA registration cannot practice pharmacy in any meaningful sense in the overwhelming majority of settings.

Under 21 U.S.C. § 824(a), the DEA may revoke a pharmacist's registration upon conviction of a felony relating to controlled substances, upon suspension or revocation of the state pharmacy license, or upon a finding that continued registration is inconsistent with the public interest.

The public interest analysis under 21 U.S.C. § 824(a)(4) examines the pharmacist's maintenance of effective controls against diversion, compliance with applicable state and local law, prior conviction record, past experience dispensing controlled substances, and any other conduct bearing on public health and safety.

Because DEA registration and pharmacy licensure are interdependent, a state licensing action that restricts or suspends the pharmacy license triggers DEA review of the registration that depends on it, and a DEA revocation creates grounds for state licensing action because operating a pharmacy without valid DEA registration violates state law.

The two tracks feed each other in ways that can accelerate a career-ending consequence well beyond what either proceeding alone would produce. Managing both tracks simultaneously, with criminal defense counsel and licensing counsel coordinating from the outset, is not a luxury in pharmacist criminal matters. It is the minimum necessary response.

What Federal Program Consequences Can Follow a Pharmacist's Criminal Conviction?

The mandatory and permissive exclusion framework under 42 U.S.C. § 1320a-7 applies to pharmacists with the same force it applies to physicians. A felony conviction relating to patient abuse or neglect in connection with the delivery of a healthcare item or service triggers mandatory exclusion under § 1320a-7(a)(2).

A felony conviction relating to healthcare fraud triggers mandatory exclusion under § 1320a-7(a)(3). A felony conviction relating to the unlawful manufacture, distribution, prescription, or dispensing of a controlled substance triggers mandatory exclusion under § 1320a-7(a)(4). Each carries a minimum five-year exclusion period with no discretion available to the OIG once the qualifying conviction exists.

For pharmacists, the § 1320a-7(a)(4) controlled substance exclusion is the most frequently implicated mandatory exclusion ground, because dispensing is the professional act and any felony conviction touching that act satisfies the statutory threshold. A pharmacist excluded from federal healthcare programs cannot dispense prescriptions covered by Medicare Part D or Medicaid, which in practice means the excluded pharmacist cannot work in any retail pharmacy, hospital pharmacy, or long-term care pharmacy that participates in those programs.

Given that virtually every pharmacy in Michigan participates in Medicare and Medicaid, mandatory exclusion is effectively a permanent bar to pharmacy practice in this state.

Medicare revocation under 42 C.F.R. § 424.535 and permissive exclusion under 42 U.S.C. § 1320a-7(b)(4), which reaches pharmacists whose state licenses have been revoked or suspended, add additional federal tracks that can operate independently of and in addition to mandatory exclusion.

The sequencing and interaction of these tracks must be analyzed at the outset of any pharmacist criminal matter, not after a plea has been entered that inadvertently satisfies a mandatory exclusion threshold.

How Do Specific Criminal Charges Affect Michigan Pharmacists?

Controlled Substance Diversion and Dispensing Violations

Controlled substance charges present the most structurally dangerous consequence profile for pharmacists, because the alleged conduct lies at the center of what the pharmacy license authorizes. DEA investigations of pharmacists typically develop from one of three sources: inventory reconciliation discrepancies identified during routine DEA inspections, prescription pattern analysis flagging statistically anomalous dispensing patterns, or referrals from the Michigan Automated Prescription System following audit triggers.

By the time a DEA agent contacts a pharmacist, the evidentiary foundation has frequently been assembled from dispensing records, DEA Form 222 controlled substance order records, and MAPS data that the pharmacy itself generated.

Challenging that evidentiary foundation, including the scope and validity of DEA inspection authority, the admissibility of records obtained through subpoenas that may have exceeded their authorized reach, and the reliability of statistical dispensing analyses used to infer diversion, is frequently the most consequential work in a pharmacist drug diversion defense.

Those challenges must begin before any statement is made to investigators, because statements made during a DEA inspection or a voluntary interview with agents are admissible regardless of whether Miranda warnings were given, and they frequently contradict the evidentiary record in ways that foreclose suppression arguments.

Billing Fraud and PBM Audit Escalation

Pharmacy billing fraud investigations typically begin not with law enforcement but with a pharmacy benefit manager audit. PBMs conduct routine claim audits that flag statistical anomalies including prescription fills without corresponding refill authorizations, duplicate billing patterns, claims for prescriptions filled for deceased patients, and billing for brand medications when generic was dispensed. A pharmacy that fails a PBM audit faces recoupment demands, contract termination, and referral to state and federal authorities, often in that sequence and on a compressed timeline.

The transition from a PBM audit to a federal False Claims Act investigation is not a large step. Pharmacies that bill Medicare Part D and Medicaid are submitting claims to federal healthcare programs, and billing irregularities in that context satisfy the threshold for False Claims Act liability, which carries civil penalties of up to $27,018 per false claim as well as treble damages.

Criminal prosecution under the healthcare fraud statute, 18 U.S.C. § 1347, which requires proof that the false billing was knowing and willful, is a further escalation that federal prosecutors in the Eastern District of Michigan have pursued with increasing frequency in pharmacy fraud cases.

A pharmacist who receives a PBM audit notice, a records request from a federal contractor, or any inquiry from CMS or the HHS-OIG should retain criminal defense counsel before responding to any of those inquiries, because the audit-to-prosecution pathway can move faster than most professionals recognize.

OWI and Alcohol-Related Offenses

A DUI or OWI charge does not trigger mandatory federal exclusion for a pharmacist in most circumstances, but it does trigger the self-reporting obligation under MCL § 333.16222(3), LARA's disciplinary authority under MCL § 333.16221, and the Board of Pharmacy's fitness review process. Because Michigan licensing boards evaluate alcohol impairment charges as fitness and public safety questions rather than criminal matters, the record created in the criminal proceeding shapes the licensing outcome in ways that the charge classification alone does not predict.

How that regulatory reframing operates for licensed healthcare professionals, including pharmacists, is developed in the firm's analysis of how Michigan licensing boards treat alcohol-related charges against licensed healthcare professionals.

Other Criminal Charges

Theft, financial crimes, and charges involving dishonesty present a specific concern for pharmacists beyond the general licensing exposure they create for all healthcare professionals.

Because the pharmacist's professional function requires managing both controlled substance inventory and financial transactions, a theft or fraud conviction unrelated to pharmacy practice may still be evaluated by the Board as directly bearing on professional fitness.

No criminal conviction involving a licensed pharmacist should be evaluated without a concurrent analysis of what the Board of Pharmacy is likely to do with it.

What Are a Michigan Pharmacist's Reporting Obligations After a Criminal Conviction?

Under MCL § 333.16222(3), a licensed pharmacist must self-report any criminal conviction to LARA within thirty days. Failure to self-report is an independent licensing violation subject to the full range of sanctions under MCL § 333.16226, in addition to whatever discipline follows from the underlying conviction.

Under MCL § 769.16a(7), the clerk of the court reports to LARA within twenty-one days of any conviction of a licensed healthcare professional for a misdemeanor involving the illegal delivery, possession, or use of alcohol or a controlled substance, or any felony.

For the categories of conviction most likely to trigger pharmacy license consequences, LARA will frequently have received court notice before the pharmacist's own thirty-day reporting window has expired.

Pharmacists also face employer reporting obligations that are separate from and often more immediate than the LARA obligation. Pharmacy chain employment agreements, hospital pharmacy credentialing bylaws, and long-term care pharmacy contracts each impose their own disclosure requirements.

A pharmacist who fails to self-report to an employer within the contractually required period may face immediate termination and an NPDB report independent of any LARA action. The self-report to LARA is a formal response to a process already in motion, and how it is drafted, including what context is provided and what remediation steps are documented, carries significant strategic weight. It should never be handled without counsel.

Voluntary Surrender and the Risks of Employer Pressure

Pharmacists, particularly those employed by retail pharmacy chains or hospital systems, face a form of institutional pressure that is less common in other healthcare professions: the employer's request to voluntarily surrender the pharmacy license or cease dispensing controlled substances pending the outcome of a criminal investigation.

That request is driven by the employer's own regulatory exposure, because a pharmacy that continues to employ a pharmacist under criminal investigation for controlled substance violations may face its own DEA and CMS scrutiny.

Voluntary surrender of a pharmacy license during an investigation is treated by LARA and by the NPDB as an adverse action and is reportable accordingly. A pharmacist who surrenders a license while a formal disciplinary proceeding is pending forecloses options that would otherwise be available, including the compliance conference mechanism, and creates a permanent adverse record that may be more damaging than the outcome of the proceeding itself would have been.

The decision whether to surrender, restrict, or continue practicing during an investigation has legal, strategic, and financial dimensions that require counsel before any response is given to an employer.

HPRP, the Substance Use Evaluation, and Why Avoiding the Program Is a Primary Defense Goal

Not every pharmacist who faces an alcohol- or drug-related criminal charge has a substance use disorder, and a criminal charge does not establish a clinical diagnosis. Whether a pharmacist has an alcohol or substance use disorder is a clinical question answered through a substance use evaluation conducted by a qualified clinician using the DSM-5 diagnostic criteria.

Patrick Barone's published analysis of the DSM-5 for substance use disorders, co-authored with Dr. Elizabeth Corby and published through the State Appellate Defender Office, provides a detailed guide to how that evaluation is conducted and what the diagnostic framework means in the criminal and licensing context.

Where the evaluation indicates a clinically significant issue, early and genuine engagement with treatment serves recovery, supports sentence mitigation, and serves the licensing defense simultaneously. Sentence mitigation for licensed pharmacists is a significant focus of this firm's practice.

The most compelling mitigation is an authentic account of what the pharmacist understands about themselves, what has changed, and what the commitment to continued practice and recovery looks like. That material is built from genuine engagement with the recovery process, developed with the guidance of counsel into a presentation that serves both the court and the Board of Pharmacy.

A pharmacist who arrives at the compliance conference with a clinically grounded substance use evaluation, a treatment record where the evaluation supports one, and documented stability has addressed the Board's primary concern before the Board has had the opportunity to mandate a program to address it. That approach directly serves the goal of avoiding HPRP.

HPRP is a monitoring program administered under MCL § 333.16105a that the Board of Pharmacy may require as a condition of continued licensure. Current HPRP contracts frequently carry a minimum term of three years, and any violation of the contract terms, including minor or technical violations, can result in contract extension.

A three-year contract can become five years or longer in practice, and the path to exit is neither predictable nor guaranteed. The program has become increasingly adversarial in its administration, relies on treatment providers whose quality is inconsistent, and imposes financial burdens that are particularly acute for pharmacists who may simultaneously be facing PBM recoupment demands or civil monetary penalties.

Avoiding HPRP entry, through a clinically honest evaluation, appropriate treatment where the evaluation supports it, objectively verifiable sustained remission, and a defense strategy built around the record that evaluation creates, are primary objectives from the first day of representation.

Where HPRP referral cannot be avoided, the defense strategy shifts to ensuring the pharmacist enters the program with counsel, understands the contract terms fully, and is positioned to comply without inadvertent violation.

Frequently Asked Questions: Criminal Charges and Michigan Pharmacists

Next Steps for Michigan Pharmacists Facing Criminal Charges

If you are a Michigan pharmacist facing any criminal charge, whether at the state or federal level, the most important step is retaining criminal defense counsel who understands not only the criminal case but the full scope of what it sets in motion across the licensing, DEA registration, and federal program tracks.

At Barone Defense Firm, we represent Michigan pharmacists where criminal charges carry consequences that move faster, and with less procedural protection, than in most other licensed professions. We engage healthcare licensing specialists as part of the defense team from the earliest possible stage, coordinating criminal defense strategy with licensing counsel as a unified team from the first day of the matter, including the day a DEA inspection occurs, or an employer audit flags a discrepancy.

To schedule a confidential consultation, call 1-877-ALL-MICH (877-255-6424), or contact us online. Consultations are available around the clock.

This page was written by Patrick Barone, founding attorney of Barone Defense Firm in Birmingham, Michigan. Patrick has represented licensed healthcare professionals at the intersection of criminal defense and professional licensing consequences for more than three decades. His published analyses include Representing Licensed Health Care Professionals Accused of Alcohol- or Drug-Related Crimes, published in the Michigan Bar Journal in October 2013, and Criminal Accusations Cause Health Care Professionals to Face Potentially Debilitating Collateral Consequences, published through the State Appellate Defender Office. His analysis of the DSM-5 for substance use disorders, co-authored with Dr. Elizabeth Corby and published through the State Appellate Defender Office, addresses the clinical and legal framework governing substance use evaluations in criminal and licensing proceedings. Patrick is a graduate of the Gerry Spence Trial Lawyers College, a Board Certified TEP (the highest level of certification) in psychodrama, sociometry, and group psychotherapy through the American Board of Examiners, and the only such credential holder in Michigan. He has been recognized as a Michigan Super Lawyer continuously since 2007 and is listed in The Best Lawyers in America. The firm's federal practice covers both the Eastern and Western Districts of Michigan.